Cargando…
Utilization of lung cancer cell lines for the study of lung cancer stem cells
Lung cancer is one of the most lethal types of cancer, and its poor prognosis is primarily due to drug resistance and cancer recurrence. As it is associated with a low five-year survival rate, lung cancer stem cells (LCSCs) have been the subject of numerous recent studies. For these studies of LCSCs...
Autores principales: | Wang, Yuyi, Jiang, Ming, Du, Chi, Yu, Yang, Liu, Yanyang, Li, Mei, Luo, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920960/ https://www.ncbi.nlm.nih.gov/pubmed/29731860 http://dx.doi.org/10.3892/ol.2018.8265 |
Ejemplares similares
-
CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
por: Wang, Yuyi, et al.
Publicado: (2018) -
Hypoxia and TGF-β1 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumors
por: Wang, Yuyi, et al.
Publicado: (2015) -
Decitabine reverses TGF-β1-induced epithelial–mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis
por: Zhang, Nan, et al.
Publicado: (2017) -
The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer
por: Liu, Yanyang, et al.
Publicado: (2016) -
Antiangiogenic therapy using endostatin increases the number of ALDH+ lung cancer stem cells by generating intratumor hypoxia
por: Yu, Yang, et al.
Publicado: (2016)